FR2287913B1 - - Google Patents

Info

Publication number
FR2287913B1
FR2287913B1 FR7531529A FR7531529A FR2287913B1 FR 2287913 B1 FR2287913 B1 FR 2287913B1 FR 7531529 A FR7531529 A FR 7531529A FR 7531529 A FR7531529 A FR 7531529A FR 2287913 B1 FR2287913 B1 FR 2287913B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7531529A
Other versions
FR2287913A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2287913A1 publication Critical patent/FR2287913A1/fr
Application granted granted Critical
Publication of FR2287913B1 publication Critical patent/FR2287913B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/14—Esterification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/10—Acylation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7531529A 1974-10-15 1975-10-15 Polymeres contenant des radicaux prostaglandines, procede pour leur preparation et leur emploi Granted FR2287913A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28419/74A IT1044797B (it) 1974-10-15 1974-10-15 Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego

Publications (2)

Publication Number Publication Date
FR2287913A1 FR2287913A1 (fr) 1976-05-14
FR2287913B1 true FR2287913B1 (fr) 1980-05-23

Family

ID=11223564

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7531529A Granted FR2287913A1 (fr) 1974-10-15 1975-10-15 Polymeres contenant des radicaux prostaglandines, procede pour leur preparation et leur emploi
FR7531530A Granted FR2287914A1 (fr) 1974-10-15 1975-10-15 Polymeres contenant des radicaux acides poly-insatures, procede pour leur preparation et leur utilisation

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7531530A Granted FR2287914A1 (fr) 1974-10-15 1975-10-15 Polymeres contenant des radicaux acides poly-insatures, procede pour leur preparation et leur utilisation

Country Status (16)

Country Link
US (2) US4228152A (fr)
JP (2) JPS51125254A (fr)
AR (1) AR213396A1 (fr)
AT (1) AT343899B (fr)
BE (1) BE834538A (fr)
CA (1) CA1050035A (fr)
CH (1) CH618190A5 (fr)
DE (2) DE2546240A1 (fr)
DK (1) DK461975A (fr)
ES (1) ES441756A1 (fr)
FR (2) FR2287913A1 (fr)
GB (2) GB1513410A (fr)
IN (1) IN142957B (fr)
IT (1) IT1044797B (fr)
NL (1) NL161462C (fr)
SE (1) SE7511468L (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902955C2 (de) * 1979-01-22 1982-09-16 Escher Wyss AG, Zürich Durchbiegungseinstellwalze
DE2902956C2 (de) * 1979-01-23 1983-05-26 Escher Wyss AG, Zürich Beheizte Durchbiegungseinstellwalze
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
JPS60190722U (ja) * 1984-05-28 1985-12-17 いすゞ自動車株式会社 ワ−クピツチ送り装置
EP0172962A1 (fr) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandines
JPS6279113A (ja) * 1985-09-30 1987-04-11 Toyoda Gosei Co Ltd ホ−ス搬送装置
US4684698A (en) * 1986-05-02 1987-08-04 Gaf Corporation Water soluble multicomplex of chlorothiazide, furosemide and poly(N-vinyl-2-pyrrolidone)
WO1992001730A1 (fr) * 1990-07-26 1992-02-06 Monsanto Company Nouvelles polyamines et procede de preparation de celles-ci
FR2707010B1 (fr) * 1993-06-25 1995-09-29 Bio Merieux
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
US6096834A (en) * 1997-04-04 2000-08-01 Monsanto Company Hydrolyzable delivery system using crosslinked polymeric resins as vehicles
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
AU7025600A (en) * 1999-09-08 2001-04-10 School Of Pharmacy, University Of London, The Uniform molecular weight polymers
WO2002010132A1 (fr) * 2000-07-31 2002-02-07 Bio Merieux Derive de succinimide utile en tant que monomere bifonctionnel polymerisable
US10113033B2 (en) 2013-03-08 2018-10-30 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
SG11201507024VA (en) * 2013-03-08 2015-10-29 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
US11207417B2 (en) 2017-03-14 2021-12-28 Polyactiva Pty Ltd Drug-polymer conjugate
MX2019010837A (es) 2017-03-14 2019-12-19 Polyactiva Pty Ltd Conjugado biodegradable de farmaco-polimero.
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
FR1603393A (fr) * 1967-12-27 1971-04-13
USRE28316E (en) 1968-09-03 1975-01-21 Entrapment compositions and processes
US3932656A (en) * 1970-09-10 1976-01-13 Alza Corporation Article of manufacture for instant release of anti-aggregation and non-thrombogenic agents to biological media
BE786747A (fr) * 1971-07-26 1973-01-26 Du Pont Copolymeres greffes statistiques de pivalolactones
US4062855A (en) * 1971-09-27 1977-12-13 University Of Washington Synthetic polymers furnishing controlled release of a biologically active component during degradation
US3811444A (en) * 1972-12-27 1974-05-21 Alza Corp Bioerodible ocular device
US3898986A (en) * 1972-12-27 1975-08-12 Alza Corp Biotransformable intrauterine device
US4145320A (en) * 1974-10-15 1979-03-20 Paolo Ferruti Polymers containing polyunsaturated acid radicals, process for their preparation and use thereof

Also Published As

Publication number Publication date
NL7512106A (nl) 1976-04-21
DK461975A (da) 1976-04-16
CA1050035A (fr) 1979-03-06
JPS543788B2 (fr) 1979-02-27
US4228152A (en) 1980-10-14
FR2287913A1 (fr) 1976-05-14
SE7511468L (sv) 1976-04-20
JPS51125254A (en) 1976-11-01
DE2546240A1 (de) 1976-04-29
NL161462C (nl) 1980-02-15
NL161462B (nl) 1979-09-17
CH618190A5 (fr) 1980-07-15
AR213396A1 (es) 1979-01-31
ATA787075A (de) 1977-10-15
DE2546241A1 (de) 1976-04-29
GB1513410A (en) 1978-06-07
ES441756A1 (es) 1977-04-01
IT1044797B (it) 1980-04-21
JPS51125497A (en) 1976-11-01
GB1524224A (en) 1978-09-06
FR2287914A1 (fr) 1976-05-14
FR2287914B1 (fr) 1978-09-22
BE834538A (fr) 1976-02-02
US4223011A (en) 1980-09-16
IN142957B (fr) 1977-09-10
AT343899B (de) 1978-06-26

Similar Documents

Publication Publication Date Title
FR2288399B3 (fr)
FI375274A (fr)
JPS5624296B2 (fr)
FR2267319B1 (fr)
DK7975A (fr)
FR2261365A1 (fr)
FR2287314B3 (fr)
FR2267444B1 (fr)
FR2272319B2 (fr)
AU495930B2 (fr)
BG19987A1 (fr)
CH569666A5 (fr)
CH1163975A4 (fr)
BG20440A1 (fr)
BG20446A1 (fr)
BG20451A1 (fr)
BG20462A1 (fr)
BG19768A1 (fr)
AU480863A (fr)
BG20638A1 (fr)
BG20854A1 (fr)
BG20883A1 (fr)
AU480758A (fr)
AU480471A (fr)
BG20885A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse